Zantac / Ranitidine (NDMA Cancer) Lawsuit in New Jersey

Time limits apply in New Jersey. Find out if you still qualify.

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Researched By
People's Justice Research Team

Verified against court records, regulatory records, and peer-reviewed research.

Last reviewed: March 2, 2026How we research

Last reviewed against primary sources: March 2, 2026

Statute of Limitations

New Jersey has a 2-year statute of limitations for personal injury claims (N.J.S.A. 2A:14-2) with the discovery rule applicable. New Jersey courts apply a Daubert-based reliability standard for expert testimony under N.J.R.E. 702, similar to federal court. New Jersey is home to major pharmaceutical manufacturers and has historically served as a pharmaceutical mass tort venue (Vioxx litigation, NPC litigation). Sanofi has significant New Jersey operations, creating strong jurisdictional contacts.

2 years from date of cancer diagnosis discovery (Daubert-based expert standard)

New Jersey Data

Exposure in New Jersey

Source: U.S. Census Bureau 2024

Source: New Jersey State Cancer Registry 2024

Source: New Jersey pharmaceutical industry demographics

Medical Resources

Clinics & Specialists in New Jersey

Rutgers Cancer Institute of New Jersey

Memorial Sloan Kettering — Basking Ridge